IVIG for autoimmune neuromuscular disorders reviewed

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1439, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autoimmune Neuromuscular Disorders

By  

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 400-408

Bentham Science Publishers

Access to resources Recommend Favorite

Tetracyclines and Neuromuscular Disorders

By  

Current Neuropharmacology, Vol. 10, Iss. 2, 2012-06 ,pp. : 134-138

Bentham Science Publishers

Access to resources Recommend Favorite

Linkage of Stress with Neuromuscular Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 3, 2016-04 ,pp. : 321-328

Bentham Science Publishers

Access to resources Recommend Favorite

Autoimmune haematological disorders

By Provan Drew  

Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. : 447-451

Royal College Of Physicians

Access to resources Recommend Favorite

Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3166-3175

Bentham Science Publishers

Access to resources Recommend Favorite